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Background: The incidence of candidaemia is steadily increasing in
n is considered a virulence factor responsible for catheter-related
candidaemia.
Objective: To investigate the capacity of bloodstream Candida iso-
lates from NICU neonates to form BF and the degree of BF produc-
tion.
Methods: 5x10 5 planktonic (PL) cells/mL were grown in YNB
medium with 2% glucose at 37°C for 24h. For BF formation, 10
6 cells/mL were grown on silicone disks placed at the bottom of
96-well plates in RPMI-1640 under constant shaking at 37°C for
48-72 h. BF production was then evaluated by XTT metabolic as-
say, safranin staining and light microscopy (LM). Documented BF
producers (CA-M61 and CP/PA71) were used as positive controls
(metabolic activity by XTT assay: 100%). Isolates that a) showed
XTT conversion ≥80% of positive controls, b) stained with safranin
and c) produced a microscopically visible dense fungal network
were considered high BF producers. XTT conversion of <80% de-
fined non-BF producers, while conversion ≥80% with inconsistent
safranin and LM findings defined low BF producers. All isolates were
tested in triplicate at 3 different experiments.
Results: A total of 31 isolates coming from equal in number NICU
neonates (12 male-19 female) with Candida bloodstream infections
were examined. Among these isolates, 58% were Candida albicans
(CA), 19% were Candida parapsilosis (CP), 7% were Candida lusita-
niae (CL) and Candida guilliermondii (CG), respectively, 3% were
Candida glabrata (CGl), Candida tropicalis (CT) and other Candida
spp. (Cs), respectively. BF production was detected in all CG and
CT isolates, in 88% of CA, in 50% of CL and in 17% of CP. CGl and
Cs isolates did not produce BF. Among CG and CT isolates, all were
high BF producers, 56% and 28% CA isolates were high and low BF
producers, respectively.
Conclusions: BF-forming capacity is a frequent characteristic
among Candida clinical isolates, especially for CG, CT, CA but not
for CGl. These results may provide the means to design novel ther-
apies for BF-related infections.
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Infection Complications of Immunosuppression in Liver
Transplant Patients: A Microbiological Study
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Background: The consequences of immunosuppression post liver
transplantation are, first, organ rejection, followed by bacterial
and fungal infections. Increasing or decreasing the serum level
beyond the advised doses of immunosuppresor has major impact
on infections. Pre-transplant health status, the complexity of the
surgery, post-transplant immunosuppression therapy, and possible
rejection are factors that affect the potential for bacterial and
fungal infections as determined in the laboratory.
Materials and methods: This study was a collaboration of the Cen-
ter of General Surgery, Liver Transplantation, Microbiology Depart-
ment and other departments of the Fundeni Clinical Institute. The
study comprised 126 liver transplant patients, of whom 61 had fun-
gal infections with Candida albicans/non-albicans and 89 had bac-
terial infections including Methicillin Resistant Staphylococcus au-
reus (MRSA), Entorococcus spp., Escherichia coli, Klebsiella spp.,
Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Acineto-
bacter baumanii calcoaceticus complex, and others. Bacteria and
fungi were isolated from typical biological products cultivated on
usual and special media after fixing the direct smear from a fresh
or colorized specimen (Gram, Fast Quick Giemsa, Methylene blue,
etc).
Results: Colonizers, bacterial episodes, and multi-bacterial sep-
sis were detected.Microorganisms detected in various pathologic
products from 126 liver transplant patients were: Staphylococcus
spp (40-43%), Enterococcus spp. (7-10%), Acinetobacter spp. (21-
25%), Pseudomonas aeruginosa (9-16%), Stenotrophomonas mal-
tophilia (2-5%), Escherichia coli (57-60%), Klebsiella spp. (3-7%),
Enterobacter spp. (3-5%), other bacteria (1-2%), Candida albicans
(32-35%), Candida glabrata (5-7%), Candida famata (7-8%), and
other non-albicans (2-3%).
Conclusion: More than 2/3 of liver transplant recipients experi-
ence infections, which are the primary cause of organ rejection.
They occur after surgical re-intervention and high-dose immuno-
suppression. More than 60% of the infections were bacterial; and
8-9% fungal.
18
Respiratory Virus Infections in Lung Transplant Recipients:
a Brazilian Study
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Marlova Caramori1, Ricardo Teixeira1, José Afonso Jr1,
Rafael Carraro1, Paulo Pego-Fernandes1, Fabio Jatene1. 1Lung
Transplant Group, Heart Institute (InCor) of Sao Paulo Medical
School, Sao Paulo, Brazil; 2Virology Laboratory, Institute of
Tropical Medicine, Sao Paulo Medical School, Sao Paulo, Brazil
Background: Respiratory virus infections (RV) infections are in-
creasingly recognized as a significant threat to immunocompro-
mised hosts. Higher rates of progression to pneumonia and major
impact on bronchiolitis obliterans are observed after lung trans-
plantation (LT).
Objectives: Describe the epidemiology of RV infections in LT recip-
ients.
Methods: Prospective cohort study of 45 LT recipients. All patients
received the same triple immunosuppressive therapy. Nasopharyn-
geal wash (NW) and bronchoalveolar lavage (BAL) were obtained
from Feb/07-Jan/08 whenever symptoms or image findings were
present. DFA and PCR were used to detect influenza A and B virus
(IFV), parainfluenza virus (PIV), metapneumovirus (hMPV), coron-
avirus, respiratory syncitial virus (RSV) and adenovirus (ADV).
Results: Twenty-six of the 45 alive patients (57.7%) followed-up
at the InCor-LT program experienced 40 respiratory events (1.53
event/patient). Respiratory symptoms were mostly observed dur-
ing fall and winter, with 86% of the events occurring between fall
and spring (median time of 425 days after LT; range 19–1487). Pa-
tients' median age was 37 years old (18 to 67), 18 were male and
18 had bilateral LT. RV were detected in 16 of the 40 episodes
(40%). Only 37% of the positive samples were obtained during win-
ter. Three patients had RV co-infection and three had two episodes
